Curis (CRIS) Interest Expenses (2011 - 2026)
Curis' (CRIS) quarterly Interest Expenses came in at $300000.0 in Q1 2026, down 45.65% YoY from $552000.0 in Q1 2025, and down 4.46% on a QoQ basis from $314000.0 in Q4 2025.
Curis (CRIS) Interest Expenses (2011 - 2026) Analysis & Trends
Curis (CRIS) has 16 years of Interest Expenses data on file, last reported at $300000.0 in Q1 2026.
- Quarterly Interest Expenses fell 45.65% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 171.11% YoY) and the FY2025 annual result came in at $211.8 million, up 0.81% from the prior year.
- Interest Expenses declined to $300000.0 in Q1 2026, from $314000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.7 million in Q4 2022 to a low of -$639000.0 in Q4 2024.
- A 5-year average of $563352.9 and a median of $552000.0 in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses slumped 304.43% — and 2025, when it jumped 149.14%.
- Tracing CRIS's Interest Expenses over 5 years: stood at $1.7 million in 2022, then sank by 109.57% to -$158000.0 in 2023, then slumped by 304.43% to -$639000.0 in 2024, then jumped by 149.14% to $314000.0 in 2025, then slipped by 4.46% to $300000.0 in 2026.
- The last three Interest Expenses figures came in at $300000.0 (Q1 2026), $314000.0 (Q4 2025), and $885000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 434,000.00 |
| Jun 30, 2025 | 434,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | -639,000.00 |
| Dec 31, 2024 | -639,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | -158,000.00 |
| Dec 31, 2023 | -158,000.00 |